13C-breath tests and liver fibrosis
- PMID: 15209155
13C-breath tests and liver fibrosis
Abstract
The evaluation of the presence and degree of liver fibrosis in patients with chronic liver disease is a fundamental diagnostic and prognostic issue. This is mainly due to the repercussions of liver fibrosis on liver function, whose derangement, in turn, is mainly responsible for the negative events of advanced liver disease. 13C-Breath Tests ((13/14)C-BTs) for the study of liver function were developed more than twenty years ago in order to non-invasively assess residual liver function in patients with various degrees of liver fibrosis, from minimal stages up to liver cirrhosis. Sequential studies that were performed over the years using various 13C-BT substrates showed that increasing degrees of liver fibrosis are paralleled by concomitant modifications in 13C-BT results. The 13C-BT probes that reportedly obtained interesting results were aminopyrine, galactose, and more recently phenylalanine. As the knowledge in this field evolved, probes for the study of specific functions, such as the 13C-Octanoate Breath Test were sought. Analysis of the published studies would seem to show that 13C-BTs alone, or in combination may provide a non-invasive picture of the functional alterations secondary to liver fibrosis. Further studies are needed to evaluate the diagnostic yield of the 13C-BT in particular clinical situations, such as in patients with normal static parameters of liver function, or after therapy.
Similar articles
-
13C-breath tests in hepatology (cytosolic liver function).Eur Rev Med Pharmacol Sci. 2004 Jan-Feb;8(1):47-9. Eur Rev Med Pharmacol Sci. 2004. PMID: 15209154 Review.
-
13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.Hepatogastroenterology. 2000 Jan-Feb;47(31):234-8. Hepatogastroenterology. 2000. PMID: 10690614
-
13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection.Aliment Pharmacol Ther. 2005 Jan 15;21(2):179-85. doi: 10.1111/j.1365-2036.2005.02317.x. Aliment Pharmacol Ther. 2005. PMID: 15679768
-
13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.Scand J Gastroenterol. 2006 Nov;41(11):1336-41. doi: 10.1080/00365520600670125. Scand J Gastroenterol. 2006. PMID: 17060128
-
13C-breath tests in the study of mitochondrial liver function.Eur Rev Med Pharmacol Sci. 2004 Jan-Feb;8(1):23-31. Eur Rev Med Pharmacol Sci. 2004. PMID: 15209152 Review.
Cited by
-
Effects of ergot alkaloids on liver function of piglets as evaluated by the (13)C-methacetin and (13)C-α-ketoisocaproic acid breath test.Toxins (Basel). 2013 Jan 15;5(1):139-61. doi: 10.3390/toxins5010139. Toxins (Basel). 2013. PMID: 23322130 Free PMC article.
-
Breath analysis using laser spectroscopic techniques: breath biomarkers, spectral fingerprints, and detection limits.Sensors (Basel). 2009;9(10):8230-62. doi: 10.3390/s91008230. Epub 2009 Oct 19. Sensors (Basel). 2009. PMID: 22408503 Free PMC article.
-
Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs.Can J Vet Res. 2011 Oct;75(4):317-20. Can J Vet Res. 2011. PMID: 22468031 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials